Literature DB >> 22057691

Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.

Jeng-Ting Tsao1, Song-Chou Hsieh, Bor-Luen Chiang, Chia-Li Yu, Shih-Chang Lin.   

Abstract

Toll-like receptor (TLR) activation and cytokines have been linked to the disease flare of systemic lupus erythematosus (SLE), yet the expression profiles of TLRs and cytokines in response to TLR activation in SLE patients remain unclear. In this study, we evaluated the expression levels of IL-10, TNF-α, interferon-γ (IFN-γ), TLR-2, TLR-4, and TLR-9 in peripheral blood mononuclear cells (PBMCs) from SLE patients and normal controls after PBMCs were stimulated with a TLR-2, TLR-4, or TLR-9 agonist. The expression levels in SLE patient group were statistically compared with those in normal control group. It was found in SLE patients that the IL-10 protein production was down-regulated after the activation of TLR-2, TLR-4, or TLR-9 and that the TNF-α protein production was decreased after the activation of TLR-2 or TLR-9, but not TLR-4. However, the transcript levels of IL-10 and TNF-α as well as the protein and transcript levels of IFN-γ were comparable between SLE and normal control groups. In addition, the TLR-2 transcript levels seem to be diminished after the activation of TLR-2, TLR-4, or TLR-9, but TLR-4 and TLR-9 transcript levels were not altered. The results indicate that the cytokine production from PBMCs in response to TLR activation is dysregulated in SLE patients, supporting the possibility that TLR activation may influence lupus disease activity through regulating cytokine production.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057691     DOI: 10.1007/s10238-011-0161-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  20 in total

Review 1.  Infections in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  E Bouza; J G Moya; P Muñoz
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

Review 2.  The role of interleukin-10 in systemic lupus erythematosus.

Authors:  Luis Llorente; Yvonne Richaud-Patin
Journal:  J Autoimmun       Date:  2003-06       Impact factor: 7.094

3.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

4.  Cross-regulation of TNF and IFN-alpha in autoimmune diseases.

Authors:  A Karolina Palucka; Jean-Philippe Blanck; Lynda Bennett; Virginia Pascual; Jacques Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-22       Impact factor: 11.205

5.  CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.

Authors:  Julie M Roda; Robin Parihar; William E Carson
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

Review 6.  Regulation of autoreactive B cell responses to endogenous TLR ligands.

Authors:  Ana Maria Avalos; Liliana Busconi; Ann Marshak-Rothstein
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 7.  Modulation of adaptive immunity with Toll-like receptors.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Semin Immunol       Date:  2009-06-06       Impact factor: 11.130

Review 8.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

9.  Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.

Authors:  Shinji Morimoto; Yoshiaki Tokano; Souichiro Nakano; Takashi Watanabe; Yoshihiro Tamayama; Akiko Mitsuo; Jun Suzuki; Hiroshi Kaneko; Iwao Sekigawa; Yoshinari Takasaki
Journal:  Autoimmunity       Date:  2009-02       Impact factor: 2.815

Review 10.  Toll-like receptors and NOD-like receptors in rheumatic diseases.

Authors:  William J McCormack; Andrew E Parker; Luke A O'Neill
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more
  9 in total

Review 1.  TLR2 and TLR4 in autoimmune diseases: a comprehensive review.

Authors:  Yu Liu; Heng Yin; Ming Zhao; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

2.  Expression of Toll‑like receptors 3 and 9 in Egyptian systemic lupus erythematosus patients.

Authors:  A S Nasr; S M Fawzy; T A Gheita; E El-Khateeb
Journal:  Z Rheumatol       Date:  2016-06       Impact factor: 1.372

3.  The decreased frequency of SIGIRR-positive CD4+ T cells in peripheral blood of patients with SLE and its correlation with disease activity.

Authors:  Dao-Yang Wang; Chao Su; Gui-Mei Chen; Hai-Feng Pan; Feng-Mei Wang; Gui-Ling Liu; Li Hao; De-Guang Wang; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2014-10-07       Impact factor: 2.316

4.  Autoregulatory function of interleukin-10-producing pre-naïve B cells is defective in systemic lupus erythematosus.

Authors:  Ji Hyun Sim; Hang-Rae Kim; Soog-Hee Chang; In Je Kim; Peter E Lipsky; Jisoo Lee
Journal:  Arthritis Res Ther       Date:  2015-07-25       Impact factor: 5.156

Review 5.  Toll-like receptors in lupus nephritis.

Authors:  Satish Kumar Devarapu; Hans-Joachim Anders
Journal:  J Biomed Sci       Date:  2018-04-12       Impact factor: 8.410

6.  Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal.

Authors:  Doua Azzouz; Aidana Omarbekova; Adriana Heguy; Dominik Schwudke; Nicolas Gisch; Brad H Rovin; Roberto Caricchio; Jill P Buyon; Alexander V Alekseyenko; Gregg J Silverman
Journal:  Ann Rheum Dis       Date:  2019-02-19       Impact factor: 19.103

7.  Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata.

Authors:  Abdullateef A Alzolibani; Zafar Rasheed; Ghada Bin Saif; Mohammed S Al-Dhubaibi; Ahmad A Al Robaee
Journal:  BBA Clin       Date:  2016-03-14

8.  VIPER regulates naive T cell activation and effector responses: Implication in TLR4 associated acute stage T cell responses.

Authors:  Subhransu Sekhar Sahoo; Belluru M Pratheek; Vikram S Meena; Tapas Kumar Nayak; P Sanjai Kumar; Saumya Bandyopadhyay; Prasanta Kumar Maiti; Subhasis Chattopadhyay
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

9.  Association Between Severity of Leptospirosis and Subsequent Major Autoimmune Diseases: A Nationwide Observational Cohort Study.

Authors:  Chih-Chung Chen; Yao-Min Hung; Lu-Ting Chiu; Mei-Chia Chou; Renin Chang; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.